Nataf F, Merienne L, Schlienger M, Lefkopoulos D, Meder J F, Touboul E, Merland J J, Devaux B, Turak B, Page P, Roux F X
Service de Neurochirurgie, Centre Hospitalier Sainte-Anne, 1, rue Cabanis, 75674 Paris Cedex 14.
Neurochirurgie. 2001 May;47(2-3 Pt 2):268-82.
After a review of the main radiosurgical published series, to evaluate our own series of 705 patients with cerebral arteriovenous malformations treated by radiosurgery alone or in combination with embolization or surgery.
and method. From January 1984 to December 1998, 705 patients were treated by a multidisciplinary team including neurosurgeons, neuroradiologists, radiophysicians and radiotherapists. Age of revelation of the cerebral arteriovenous malformations ranged between birth to 73 years (mean 27, median 25). Age at time of radiosurgery ranged between 7 and 75 years (mean 33, median 31). There were 410 males for 295 females (sex- ratio 1.4). Symptoms of revelation were hemorrhage for 59%, seizures for 23%, headaches for 14% and progressive deficits for 4%. Discovery of cerebral arteriovenous malformation was fortuitous in 4% of cases. Repartition following Spetzler's grading was 12% in grade I, 36% in grade II, 40% in grade III, 12% in grade IV and 0% in grade V. Maximal size ranged between 4 and 60 mm (mean 23, median 20). Volume ranged between 0.2 and 24.3 cc (mean 3.8, median 2.8). Majority of cerebral arteriovenous malformations were large size (42% with size higher than 25 mm) and large volume (54% higher than 10 cc. 54% of patients had treatment prior radiosurgery: 38% had embolization, 10% were operated, 4% were treated by radiosurgery (reirradiation) and 3% were operated and embolized.
Overall complete obliteration rate was 55%. The obliteration rate was correlated with size (77% for cAVMs lower than 15 mm, 62% for cerebral arteriovenous malformations between 15 and 25 mm, and 44% for cerebral arteriovenous malformations higher than 25 mm), with volume (94% for cerebral arteriovenous malformations lower than 1 cc, 64% between 1 and 4 cc, 48% between 4 and 10 cc, and 62% for cerebral arteriovenous malformations higher than 10 cc), dose at reference isodose, minimal dose, morphological parameters (presence of dural components, arteriolovenous fistula, plexiform angioarchitecture, arterial steal, arterial recruitment, deep exclusive drainage, venous plicature, venous confluence, venous ectasia, venous reflux), sectional topography and good recovery of the target. Embolization was a confusion factor not associated with obliteration rate. After multivariate analysis, only Dmin and complete coverage of the cerebral arteriovenous malformations were correlated with obliteration rate. Delay of obliteration was significantly correlated after multivariate analysis with Dmin, complete coverage, arteriolovenulary angioarchitecture (positive correlation) and venous ectasia (negative correlation).
Overall complete obliteration rate is unreliable data to assess efficacy of radiosurgical method in the tretment of cerebral arteriovenous malformations. The obliteration rate must be interpretated after stratification on several morphological and dosimetric parameters.
在回顾了已发表的主要放射外科系列研究后,对我们自己治疗的705例脑动静脉畸形患者的系列研究进行评估,这些患者接受了单纯放射外科治疗,或联合栓塞或手术治疗。
1984年1月至1998年12月,由神经外科医生、神经放射科医生、放射物理师和放射治疗师组成的多学科团队对705例患者进行了治疗。脑动静脉畸形被发现时的年龄在出生至73岁之间(平均27岁,中位数25岁)。接受放射外科治疗时的年龄在7至75岁之间(平均33岁,中位数31岁)。男性410例,女性295例(性别比1.4)。发现时的症状为出血占59%,癫痫占23%,头痛占14%,进行性神经功能缺损占4%。4%的病例脑动静脉畸形是偶然发现的。根据斯佩茨勒分级的分布情况为:Ⅰ级占12%,Ⅱ级占36%,Ⅲ级占40%,Ⅳ级占12%,Ⅴ级占0%。最大尺寸在4至60毫米之间(平均23毫米,中位数20毫米)。体积在0.2至24.3立方厘米之间(平均3.8立方厘米,中位数2.8立方厘米)。大多数脑动静脉畸形尺寸较大(42%尺寸大于25毫米)且体积较大(54%大于10立方厘米)。54%的患者在接受放射外科治疗前接受过治疗:38%接受过栓塞,10%接受过手术,4%接受过放射外科治疗(再照射),3%接受过手术和栓塞。
总体完全闭塞率为55%。闭塞率与尺寸相关(直径小于15毫米的脑动静脉畸形闭塞率为77%,直径在15至25毫米之间的脑动静脉畸形闭塞率为62%,直径大于25毫米的脑动静脉畸形闭塞率为44%),与体积相关(体积小于1立方厘米的脑动静脉畸形闭塞率为94%,1至4立方厘米之间的闭塞率为64%,4至10立方厘米之间的闭塞率为48%,体积大于10立方厘米的脑动静脉畸形闭塞率为62%),参考等剂量线处的剂量、最小剂量、形态学参数(硬脑膜成分、动静脉瘘、丛状血管结构、动脉盗血、动脉募集、深部单独引流、静脉襻、静脉汇合、静脉扩张、静脉反流的存在情况)、断层解剖位置以及靶区的良好恢复情况有关。栓塞是一个与闭塞率无关的干扰因素。多因素分析后,只有最小剂量(Dmin)和脑动静脉畸形的完全覆盖与闭塞率相关。多因素分析后闭塞延迟与最小剂量、完全覆盖、动静脉血管结构(正相关)和静脉扩张(负相关)显著相关。
总体完全闭塞率是评估放射外科治疗脑动静脉畸形疗效的不可靠数据。闭塞率必须在根据多个形态学和剂量学参数进行分层后进行解读。